Total medical devices industry deals worth $2.8bn were announced globally for March 2022, with the $240m acquisition of Ivenix being the sector’s biggest investment, according to GlobalData’s deals database.

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 33.02% over the previous month of $4.21bn and a drop of 82.7% when compared with the last 12-month average of $16.26bn.

In terms of number of deals, the sector saw a rise of 1.52% with 200 deals in March 2022 when compared to the last 12-month average of 197 deals.

In value terms, North America led the activity with deals worth $1.87bn in March 2022.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

medical devices industry deals in March 2022: Top deals

The top five deals accounted for 28% of the overall value during March 2022.

The combined value of the top five deals stood at $790m, against the overall value of $2.8bn recorded for the month.

The top five medical devices industry deals of March 2022 tracked by GlobalData were:

1) Fresenius Kabi $240m acquisition deal with Ivenix

2) The $200m venture financing of DNAnexus by Blackstone Growth,Foresite Capital Management,GV Management Co,Innovatus Capital Partners,Northpond Ventures and Perceptive Advisors

3) Fidelity Management & Research,Redmile Group and T Rowe Price Associates $125m private equity deal with Saluda Medical

4) The $125m venture financing of BillionToOne by Adams Street Partners,Baillie Gifford,Civilization Ventures,Fifty Years Fund,Hummingbird Ventures,Libertus Capital,NeoTribe Ventures,Norwest Venture Partners,Pacific 8 Ventures and Time BioVentures

5) Artiman Ventures,Blue Water Life Science Advisors,Cedars-Sinai Medical Center,Healthcare of Ontario Pension Plan,John Doerr,ND Capital,Nissim Capital,Ping An Voyager Partners and Pitango Venture Capital $100m venture financing deal with Visby Medical